Previous studies have reported that EML4-ALK occurs at a significantly higher frequency in adenocarcinoma [5]–[7], [12], [15], [18], [19], while some studies have also reported that EML4-ALK occurs at a similar frequency in non-adenocarcinomas [8], [13], [14], [16], [17]. Here, EML4 is linked to adenocarcinoma.